RxDoctor Payments Data

Louis Spencer, MD

Family Medicine · Cartersville, GANPI 1669642484

Payments from drug & device makers

$10,021in general payments, 2019–2025

Across 776 payments — averaging $12.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • AstraZeneca$494
  • Lilly USA, LLC$438
  • Amgen$368
  • Sanofi-aventis U.S. LLC$358
  • plus $4K from 44 others

What the payments were for

  • Food & beverage$9,97099%
  • Education$511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,021 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$127,587
Medicare patients
110
Services billed
10,838

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide210$300,719
MounjaroTirzepatide91$137,518
JanuviaSitagliptin Phosphate61$62,140
XareltoRivaroxaban38$52,916
FarxigaDapagliflozin Propanediol42$49,889
VraylarCariprazine Hcl22$32,828
EliquisApixaban25$31,723
RybelsusSemaglutide18$30,522
LinzessLinaclotide31$29,608
Repatha SureclickEvolocumab35$27,003
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$24,588
Breztri AerosphereBudesonide/Glycopyr/Formoterol29$23,072
JardianceEmpagliflozin12$15,321
VascepaIcosapent Ethyl18$7,040
Albuterol Sulfate HfaAlbuterol Sulfate116$4,138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,746$331,241228 claims
Lilly USA, LLCMounjaro$438$137,51891 claims
AstraZenecaFarxiga, Breztri Aerosphere$494$72,96171 claims
AbbVieVraylar, Linzess, Synthroid$2,278$64,31472 claims
MerckJanuvia$201$62,14061 claims
Johnson & JohnsonXarelto$89$52,91638 claims
PfizerEliquis$312$31,72325 claims
GSKTrelegy Ellipta$147$24,58831 claims
Boehringer IngelheimJardiance$113$15,32112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Cartersville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →